Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abciximab
advances in neurology
adverse drug reaction
air transport
algorithm
anatomy of
aneurysm, intracranial
aneurysm, intracranial, treatment of
angiography, cerebral
angiography, neurologic complications with
angiography, posterior fossa
anterior cerebral artery
anterior cerebral artery territory infarction
anterior cerebral artery, emboli to
anterior cerebral artery, occlusion of
anterior temporal branch of posterior cerebral artery
anticoagulant, treatment
anticoagulant, treatment in CVD
anticonvulsants
antiphospholipid antibodies
arterial dissection
arterial dissection, basilar
arterial dissection, vertebral
arterial perforation
Asians
aspirin
atrial fibrillation
baroreceptors
BASICS trial
basilar artery
basilar artery occlusion
basilar artery stenosis
BEST trial
biologic markers
biotinidase deficiency
blacks
blood brain barrier
blood pressure
blood pressure after stroke
brainstem, infarction of
brainstem, ischemia
brainstem, lesion of
bridge therapy
call 911
cardiac catheterization, neurologic complications
cardiac surgery
cardiovascular disease
carotid artery
carotid artery atherosclerosis
carotid artery disease
carotid artery occlusion, intracranial
carotid artery occlusion, neck
carotid artery stenosis
carotid artery stenosis, preocclusive
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, angiography, false negative
CAT scan, angiography, false positive
CAT scan, angiography, source images
CAT scan, contrast enhanced
CAT scan, contrast extravasation
CAT scan, dense artery sign
CAT scan, disappearing lesion on
CAT scan, false negative
CAT scan, false positive
CAT scan, helical
CAT scan, mismatch between perfusion/diffusion
CAT scan, perfusion
CAT scan, venography
central artery of Percheron
central retinal artery occlusion
central venous catheter
cerebellar infarction
cerebral edema
cerebral embolism
cerebral embolism, cardiac origin
cerebral embolism, mechanical extraction
cerebral infarction
cerebral infarction, hemorrhagic
cerebral ischemia
cerebral veins
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebral venous thrombosis, etiology
cerebral venous thrombosis, recurrent
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, arterial occlusion, location
cerebrovascular accident, awakening with
cerebrovascular accident, bilateral
cerebrovascular accident, circadian rhythm
cerebrovascular accident, complications with
cerebrovascular accident, cost of
cerebrovascular accident, etiology
cerebrovascular accident, infancy and childhood
cerebrovascular accident, in-hospital
cerebrovascular accident, location of
cerebrovascular accident, multiple
cerebrovascular accident, pathophysiology
cerebrovascular accident, postoperative
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, racial differences
cerebrovascular accident, recurrent
cerebrovascular accident, seizure with
cerebrovascular accident, severity
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, thromobolytic agents in treatment, early dramatic recovery
cerebrovascular accident, time to treatment
cerebrovascular accident, vascular territory involved
cerebrovascular accident, volume
cerebrovascular accident, women
cerebrovascular accident, work up for
cerebrovascular accident, young adult
cerebrovascular disease
cerebrovascular disease, treatment of
chemotherapy, intra-arterial
children
CHOICE trial
circle of Willis
Clinical Pathologic Conference(C.P.C.)
clot retrieval
cocaine
coma
Community hospital
comorbidities
complications
controversies in neurology
coronary artery bypass
cortical vein thrombosis
cost
cost effectiveness
coumarin
coumarin, stopping treatment
craniectomy, decompressive
craniotomy
critical care unit
critical pathway
D-dimer
dehydration
delay in diagnosis
dementia
dense basilar artery sign
dense posterior cerebral artery sign
diabetes insipidus
diplopia
disability, neurological
dizziness
drop attacks
dural sinus thrombosis
edema, facial
efficacy
embolism
embolism, vertebral-basilar artery
embolization, therapeutic
emergencies, neurologic
emergency medical technicians
endarterectomy, carotid
endarterectomy, carotid-complications of
endarterectomy, carotid-indications for
endovascular therapy
endovascular therapy, time window
epidemiology of neurology
evidence-based research
Factor V Leiden
fibrinolytic agents
fibrinolytic agents, combined IA and IV
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic agents, intra-arterial local infusion
fibrinolytic agents, intra-venous local infusion
fibrinolytic therapy, selection criteria
fibrinolytic therapy, timing of administration
fresh frozen plasma
gadolinium
gaze palsy
glucose level, serum
head injury
headache
headache, severe
heart valve surgery
hematoma, intracerebral
hemianopia
hemianopia, homonymous
hemiparesis
hemiplegia
hemorrhagic diathesis
heparin
herniation syndromes, intracranial
hippocampal infarction
hydrocephalus
hyperintense vessel sign
hyperperfusion syndrome
hypertension
iatrogenic neurologic disorders
incidence
infarct core
in-hospital
institutional review board
internal carotid artery
internal cerebral vein
internet
intracerebral hemorrhage
intracerebral hemorrhage, progression of
intracerebral hemorrhage, small
intracranial hemorrhage
intracranial pressure, increased
intubation
ischemic penumbra
level of consciousness, decreased
lithium
lumbar puncture, complications of
malformation, vascular
malformation, vascular, cerebral
mastoiditis
mental status, abnormal
MERCI trial
middle cerebral artery
middle cerebral artery territory infarction
middle cerebral artery territory infarction, malignant
middle cerebral artery, emboli to
middle cerebral artery, occlusion of
misdiagnosis
mortality
MR CLEAN
MRI
MRI, abnormal
MRI, ADC maps
MRI, angiography
MRI, angiography, contrast enhanced
MRI, CAT scan compared to
MRI, cerebrovascular disease
MRI, contrast enhanced
MRI, diffusion weighted
MRI, disappearing lesion on
MRI, early changes in CVA
MRI, emergent
MRI, false negative
MRI, gradient-echo
MRI, mismatch between perfusion/diffusion
MRI, perfusion
MRI, serial
MRI, venography
multimodal neuroimaging
nerve block
neuritis, causes of
neurologic complications of, surgery
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic examination, focal
neurologic recovery
neurologic signs
neurologic symptoms
neuroprotective agents
neuroradiology, interventional
NIH stroke scale
nystagmus
occipital lobe, infarction
old age, neurology of
oral contraceptives
oral contraceptives, cerbrovascular disease and
oral contraceptives, neurologic complications with
otitis, neurologic complications with
outcome research
pitfalls
platelet inhibiting drugs
platelet inhibiting drugs, combined
posterior cerebral artery
posterior cerebral artery embolism
posterior cerebral artery occlusion
posterior cerebral artery territory infarction
posterior cerebral artery, fetal type
posterior circulation stroke
postoperative neurologic complications
postpartum
practice guidelines
pregnancy, neurologic complications in
prethrombotic state
prognosis
protein C deficiency
protein S deficiency
protocol violations
recanalization, arterial
recanalization, venous
reperfusion
Retriever Device
REVASCAT trials
revascularization, surgical
review article
risk factors
risk-benefit assessment
safety
screening
seizure
seizure, acute symptomatic
seizure, complications following
seizure, prevention of
single photon emission computed tomography
solitaire device
stent, carotid artery
stent, vertebral artery
streptokinase
stroke center
stroke disability scale
stroke protocol
stroke team
stroke unit
stroke unit, mobile
subarachnoid hemorrhage
subclavian vein catheterization
superior sagittal sinus thrombosis
SWIFT PRIME Trials
T lesion of MCA-ICA
telemedicine
teleneurology
teleradiology
thalamus, infarction of
thalamus, infarction, bilateral
thalamus, lesion of
thalamus, lesion of-bilateral
thrombectomy
thrombin inhibitor
thrombolysis, mechanical
time is brain
tissue plasminogen activator, intravenous
top of the basilar syndrome
transluminal angioplasty, basilar artery
transluminal angioplasty, carotid artery
transluminal angioplasty, intracranial
transluminal angioplasty, intracranial-indications for
transluminal angioplasty, middle cerebral artery
transluminal angioplasty, vertebral artery
transport of patient
treatment of neurologic disorder
trial design
uncal herniation
unconsciousness
unconsciousness, transient
urokinase
vein of Galen
venogram, cerebral
vertebral artery occlusion
vertebral artery stenosis
vertebral-basilar artery, intraluminal clot
vertebral-basilar insufficiency
vertigo
vestibular function, tests of
visual field defect
visual loss
visual loss, sudden
visual loss, sudden-unilateral
vitamin K
workup
Showing articles 450 to 500 of 3600 << Previous Next >>

Do the Brain Attack Coalition's Criteria for Stroke Centers Improve Care for Ischemic Stroke?
Neurol 64:422-427, Douglas, V.C., et al, 2005

Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 36:916-921, Adams,H.,et al, 2005

Time to Hospital Arrival, Use of Thrombolytics, and In-Hospital Outcomes in Ischemic Stroke
Neurol 64:2115-2120, Qureshi,A.I.,et al, 2005

Intravenous rt-PA for Acute Stroke: Comparing Its Effectiveness in Younger and Older Patients
JNNP 76:1234-1237, Mouradian,M.S.,et al, 2005

MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
Stroke 36:1939-1943, Kang,D.-W.,et al, 2005

REACH Clinical Feasibility of a Rural Telestroke Network
Stroke 36:2018-2020, Hess,D.C.,et al, 2005

Agressive Therapy With Intravenous Abciximab and Intra-Arterial rtPA and Additional PTA/Stenting Improves Clinical Outcome in Acute Vertebrobasilar Occlusion
Stroke 36:1160-1165, Eckert,B.,et al, 2005

Perfusion Computed Tomography: Prediction of Final Infarct Extent and Stroke Outcome
Ann Neurol 58:672-679,661, Parsons,M.W.,et al, 2005

Economic Benefit of Increasing Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in the United States
Stroke 36:2500-2503, Demaerschalk,B.M. &Yip,T.R., 2005

Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
Stroke 36:2497-2499, Smith,E.E.,et al, 2005

Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (=80 Years) Stroke Patients
Stroke 36:2421-2425, Berrouschot,J.,et al, 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005

IV Thrombolysis in Patients with Acute Stroke Due to Spontaneous Carotid Dissection
Neurol 64:1612-1614, Georgiadis,D.,et al, 2005

Utility of an Ultrafast Magnetic Resonance Imaging Protocol in Recent and Semi-Recent Strokes
JNNP 76:1002-1005,905, U-King-Im,J.M.,et al, 2005

Transcranial Low-Frequency Ultrasound-Mediated Thrombolysis in Brain Ischemia
Stroke 36:1441-1446, Daffertshofer,M.,et al, 2005

Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO)
Stroke 36:1512-1518, Wojner-Alexandrov,A.,et al, 2005

Predictors of Early Arterial Reocclusion After Tissue Plasminogen Activator-Induced Recanalization in Acute Ischemic Stroke
Stroke 36:1452-1456, Rubiera,M.,et al, 2005

Clinical Importance of Microbleeds in Patients Receiving IV Thrombolysis
Neurol 65:1175-1178, Kakuda,W.,et al, 2005

Thrombolysis in Stroke Patients Aged 80 Years and Older: Swiss Survey of IV Thrombolysis
Neurol 65:1795-1798,1690, Engelter,S.T.,et al, 2005

Is Hospitalization After TIA Cost-Effective on the Basis of Treatment With tPA?
Neurol 65:1799-1801, Nguyen-Huynh,M.N. &Johnson,S.C., 2005

Posterior Cerebral Artery Stroke
e medicine, Hill,M.D., 2005

The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase
Stroke 36:66-73, Hacke,W.,et al, 2005

Multiple Cerebral Microbleeds:MRI Marker of a Diffuse Hemorrhage-Prone State
J Neuroimaging 14:54-57, Chalela,J.A.,et al, 2004

Should Thrombolysis be Given to a Stroke Patient Refusing Therapy Due to Profound Anosognosia?
Neurol 63:2440, Katz,J.M. &Segal,A.Z., 2004

Fibrinogen-Depleting Agents for Acute Ischemic Stroke
Stroke 36:173-174, Liu,M.,et al, 2004

Thrombolysis for Acute Ischemic Stroke
Stroke 35:2914-2915, Wardlaw,J.,et al, 2004

Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke
NEJM 351:2170-2178, Alexandrov,A.V.,et al, 2004

Thrombylosis for Cerebral Vein and Dural Sinus Thrombosis
Stroke 35:2428, Ciccone,A.,et al, 2004

Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment Trial
Stroke 35:2418-2424, Ingall,T.J.,et al, 2004

Predictors of In-Hospital Mortality in Patients with Acute Ischemic Stroke Treated with Thrombolytic Therapy
JAMA 292:1831-1838, Heuschmann,P.U.,et al, 2004

Lack of Improvement in Patients with Acute Stroke After Treatment with Thrombolytic Therapy
JAMA 292:1839-1844, Saposnik,G.,et al, 2004

Long-Term Outcome After Intravenous Thrombolysis of Basilar Artery Occlusion
JAMA 292:1862-1866, Lindsberg,P.J.,et al, 2004

Thrombolytic Therapy in Stroke-Related Trauma
Conn Med 68:551-553, Finelli,P.F. &Beland,D., 2004

Systemic Inflammatory Response Depends on Initial Stroke Severity but is Attenuated by Successful Thrombolysis
Stroke 35:2128, Audebert,H.J.,et al, 2004

Are There Time-Dependent Differences in Diffusion and Perfusion Within the First 6 Hours After Stroke Onset?
Stroke 35:2099, Fiehler,J.,et al, 2004

Predicting Major Neurological Improvement With Intravenous Recombinant Tissue Plasminogen Activator Treatment of Stroke
Stroke 35:147-150, Brown,D.L.,et al, 2004

Early MRI Findings in Patients Receiving Tissue Plasminogen Activator Predict Outcome: Insights into the Pathophysiology of Acute Stroke in the Thrombolysis Era
Ann Neurol 55:105-112, Chalela,J.A.,et al, 2004

Intravenous r-TPA in Vertebrobasilar Acute Infarcts
Neurol 62:1854-1856, Montavont,A.,et al, 2004

Predictors of Hyperacute Clinical Worsening in Ischemic Stroke Patients Receiving Thrombolytic Therapy
Stroke 35:1903-1907, Leigh,R.,et al, 2004

Prediction of Hospital Disposition After Thrombolysis for Acute Ischemic Stroke Using the National Institutes of Health Stroke Scale
Arch Neurol 61:1061-1064, Schlegel,D.J.,et al, 2004

Remote Evaluation of Acute Ischemic Stroke in Rural Community Hospitals in Georgia
Stroke 35:1763-1768, Wang,S.,et al, 2004

Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Arch Neurol 61:346-350, Katzan,I.L.,et al, 2004

Association of Outcome with Early Stroke Treatment:Pooled Analysis of ATLANTIS, ECASS, and NINDS rt-PA Stroke Trials
Lancet 363:768-774, The ATLANTIS,ECASS,and NINDS rt-PA Study Group, 2004

Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical Practice
Stroke 34:2847-2850, Graham,G.D., 2003

"Computed Tomography-Negative" Intracerebral Hemorrhage
Arch Neurol 60:1156-1159, Packard,A.S.,et al, 2003

Use of a Field-to-Stroke Center Helicopter Transport Program to Extend Thrombolytic Therapy to Rural Residents
Stroke 34:729, Silliman,S.L.,et al, 2003

Telemedicine for Acute Stroke
Stroke 34:725, LaMonte,M.P.,et al, 2003

Early Major Ischemic Changes on Computed Tomography Should Preclude Use of Tissue Plaminogen Activator
Stroke 34:820-821,822, von Kummer,R., 2003

Early Major Ischemic Changes on Computed Tomography Should Not Preclude Use of Tissue Plasminogen Activator
Stroke 34:821-822,822, Lyden,P.,et al, 2003

Efficacy of IV Tisuse Plasminogen Activator in Acute Stroke
Neurol 61:71-75, Hsia,A.W.,et al, 2003



Showing articles 450 to 500 of 3600 << Previous Next >>